Reply to Eschenauer Et Al
Overview
Overview
Journal
Clin Infect Dis
Publisher
Oxford University Press
Specialty
Infectious Diseases
Date
2014 Nov 6
PMID
25371486
Authors
Affiliations
Affiliations
Soon will be listed here.
References
1.
Sakoulas G, Eliopoulos G, Alder J, Eliopoulos C
. Efficacy of daptomycin in experimental endocarditis due to methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother. 2003; 47(5):1714-8.
PMC: 153308.
DOI: 10.1128/AAC.47.5.1714-1718.2003.
View
2.
Suvarna V
. Investigator initiated trials (IITs). Perspect Clin Res. 2013; 3(4):119-21.
PMC: 3530977.
DOI: 10.4103/2229-3485.103591.
View
3.
Levine D, Fromm B, Reddy B
. Slow response to vancomycin or vancomycin plus rifampin in methicillin-resistant Staphylococcus aureus endocarditis. Ann Intern Med. 1991; 115(9):674-80.
DOI: 10.7326/0003-4819-115-9-674.
View
4.
Kullar R, McKinnell J, Sakoulas G
. Avoiding the perfect storm: the biologic and clinical case for reevaluating the 7-day expectation for methicillin-resistant Staphylococcus aureus bacteremia before switching therapy. Clin Infect Dis. 2014; 59(10):1455-61.
PMC: 4215066.
DOI: 10.1093/cid/ciu583.
View
5.
Kullar R, Davis S, Kaye K, Levine D, Pogue J, Rybak M
. Implementation of an antimicrobial stewardship pathway with daptomycin for optimal treatment of methicillin-resistant Staphylococcus aureus bacteremia. Pharmacotherapy. 2013; 33(1):3-10.
DOI: 10.1002/phar.1220.
View